Patient Management

CURATED BY: Angela C. Combs,
MN, ARNP, PMHNP-BC
Researchers of a study aimed to evaluate the broad impact of tardive dyskinesia (TD) on patients' physical, emotional, and social functioning....

Patient Management Guidelines

Consensus Input on Assessing the Impact of Tardive Dyskinesia

An advisory panel developed consensus recommendations on the assessment of the functional impact of tardive dyskinesia in clinical settings.

CURATED BY:
Angela C. Combs,
MN, ARNP, PMHNP-BC

Treatment Recommendations

Using the American Academy of Neurology Risk of Bias Classification system and Scottish Intercollegiate Guidelines Network framework, researchers performed a systematic review of studies on the treatment of tardive dyskinesia and provide treatment recommendations.

CURATED BY:
Angela C. Combs,
MN, ARNP, PMHNP-BC

American Academy of Neurology

An evidence-based guideline from the American Academy of Neurology provides treatment recommendations for tardive syndromes, as well as a treatment algorithm.

CURATED BY:
Angela C. Combs,
MN, ARNP, PMHNP-BC

American Psychiatric Association Practice Guideline

Presented in a standardized format, the American Psychiatric Association practice guidelines provide evidence-based recommendations for the assessment and treatment of psychiatric disorders.

CURATED BY:
Angela C. Combs,
MN, ARNP, PMHNP-BC

Articles

Life with Tardive Dyskinesia: A Patient Journey

Keith Wapniarski's life took a drastic turn after a car accident in 1986, which led to severe migraines and pain....
CURATED BY:
Michael Asbach,
DMSc, PA-C, Psych-CAQ

Tardive Dyskinesia Impact Scale Offers Comprehensive Patient Perspective on Physical and Socioemotional Impacts

Tardive dyskinesia (TD) is a movement disorder caused by prolonged use of dopamine receptor-blocking medications, significantly affecting physical, cognitive, and...
CURATED BY:
Jennifer A. Sampang,
PhD, MSN, APRN, PMHNP-BC

Experts Discuss Managing Co-Occurring Drug-Induced Parkinsonism and Tardive Dyskinesia

In a discussion led by Rakesh Jain, MD, MPH, experts Rajeev Kumar, MD, and Jonathan Meyer, MD, explored the complexities...
CURATED BY:
Jeremy Schreiber,
MSN, PMHNP-BC

Experts Develop Impact-TD Scale to Assess Tardive Dyskinesia’s Daily Impact

A consensus panel of nine experts developed the Impact-TD scale to assess how tardive dyskinesia (TD) affects daily functioning. This...
CURATED BY:
Jeremy Schreiber,
MSN, PMHNP-BC

Study Reveals Overprescription of Benztropine for Movement Disorders, Urges Better Guideline Adherence

Benztropine, an anticholinergic medication, is prescribed short-term for drug-induced movement disorders but can worsen tardive dyskinesia symptoms. Researchers of a...
CURATED BY:
Angela C. Combs,
MN, ARNP, PMHNP-BC

Tardive Dyskinesia in Schizophrenia: Case Study Highlights Challenges and Treatment Strategies

Tardive dyskinesia (TD) syndromes involve abnormal involuntary movements, ranging from mild to severe, and are linked to increased mortality in...
CURATED BY:
Jennifer A. Sampang,
PhD, MSN, APRN, PMHNP-BC
Share